BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32140563)

  • 21. CD13/aminopeptidase N and murine cytomegalovirus infection.
    Kasman LM
    Virology; 2005 Mar; 334(1):1-9. PubMed ID: 15749117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymph Node Macrophages Restrict Murine Cytomegalovirus Dissemination.
    Farrell HE; Davis-Poynter N; Bruce K; Lawler C; Dolken L; Mach M; Stevenson PG
    J Virol; 2015 Jul; 89(14):7147-58. PubMed ID: 25926638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65).
    Morello CS; Cranmer LD; Spector DH
    J Virol; 2000 Apr; 74(8):3696-708. PubMed ID: 10729145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.
    Wu Z; Qin R; Wang L; Bosso M; Scherer M; Stamminger T; Hotter D; Mertens T; Frascaroli G
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and Mechanism of Action of Low Dose Emetine against Human Cytomegalovirus.
    Mukhopadhyay R; Roy S; Venkatadri R; Su YP; Ye W; Barnaeva E; Mathews Griner L; Southall N; Hu X; Wang AQ; Xu X; Dulcey AE; Marugan JJ; Ferrer M; Arav-Boger R
    PLoS Pathog; 2016 Jun; 12(6):e1005717. PubMed ID: 27336364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppressor of Cytokine Signaling 1 (SOCS1) and SOCS3 Are Stimulated within the Eye during Experimental Murine Cytomegalovirus Retinitis in Mice with Retrovirus-Induced Immunosuppression.
    Chien H; Alston CI; Dix RD
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Murine Cytomegalovirus Glycoprotein O Promotes Epithelial Cell Infection
    Yunis J; Farrell HE; Bruce K; Lawler C; Wyer O; Davis-Poynter N; Brizić I; Jonjić S; Adler B; Stevenson PG
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30404805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential Application of TALENs against Murine Cytomegalovirus Latent Infections.
    Chen SJ; Chen YC
    Viruses; 2019 May; 11(5):. PubMed ID: 31058862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel functions of tyrosine kinase 2 in the antiviral defense against murine cytomegalovirus.
    Strobl B; Bubic I; Bruns U; Steinborn R; Lajko R; Kolbe T; Karaghiosoff M; Kalinke U; Jonjic S; Müller M
    J Immunol; 2005 Sep; 175(6):4000-8. PubMed ID: 16148148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity.
    Pautasso S; Galitska G; Dell'Oste V; Biolatti M; Cagliani R; Forni D; De Andrea M; Gariglio M; Sironi M; Landolfo S
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Host Genetics of Cytomegalovirus Pathogenesis.
    Sezgin E; An P; Winkler CA
    Front Genet; 2019; 10():616. PubMed ID: 31396258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant.
    MacDonald MR; Li XY; Stenberg RM; Campbell AE; Virgin HW
    J Virol; 1998 Jan; 72(1):442-51. PubMed ID: 9420244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dominance of virus over host factors in cross-species activation of human cytomegalovirus early gene expression.
    García-Ramírez JJ; Ruchti F; Huang H; Simmen K; Angulo A; Ghazal P
    J Virol; 2001 Jan; 75(1):26-35. PubMed ID: 11119570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adoptive transfer of cytomegalovirus-specific effector CD4+ T cells provides antiviral protection from murine CMV infection.
    Jeitziner SM; Walton SM; Torti N; Oxenius A
    Eur J Immunol; 2013 Nov; 43(11):2886-95. PubMed ID: 23921569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type I Interferon Released by Myeloid Dendritic Cells Reversibly Impairs Cytomegalovirus Replication by Inhibiting Immediate Early Gene Expression.
    Holzki JK; Dağ F; Dekhtiarenko I; Rand U; Casalegno-Garduño R; Trittel S; May T; Riese P; Čičin-Šain L
    J Virol; 2015 Oct; 89(19):9886-95. PubMed ID: 26202227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Don't Go Breaking My Heart: MCMV as a Model for HCMV-Associated Cardiovascular Diseases.
    Bonavita CM; Cardin RD
    Pathogens; 2021 May; 10(5):. PubMed ID: 34069957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A murine model with murine cytomegalovirus infection resulting in colon inflammation after allogeneic skin transplantation].
    Zhang W; Gan L; Li RP; Chen JX; Wang ML
    Bing Du Xue Bao; 2011 Jan; 27(1):1-10. PubMed ID: 21462500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a Primary Human Cell Model for the Study of Human Cytomegalovirus Replication and Spread within Salivary Epithelium.
    Morrison KM; Beucler MJ; Campbell EO; White MA; Boody RE; Wilson KC; Miller WE
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30404806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms.
    Tu CC; Arnolds KL; O'Connor CM; Spencer JV
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Murine Cytomegalovirus Exploits Olfaction To Enter New Hosts.
    Farrell HE; Lawler C; Tan CS; MacDonald K; Bruce K; Mach M; Davis-Poynter N; Stevenson PG
    mBio; 2016 Apr; 7(2):e00251-16. PubMed ID: 27118588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.